Skip to Content

W P97 (Primaquine Phosphate 26.3 mg (15 mg base))

Pill with imprint W P97 is Pink, Round and has been identified as Primaquine Phosphate 26.3 mg (15 mg base). It is supplied by Sanofi-Aventis.

Primaquine is used in the treatment of malaria prevention; malaria; pneumocystis pneumonia and belongs to the drug class antimalarial quinolines. FDA has not classified the drug for risk during pregnancy. Primaquine 26.3 mg (15 mg base) is not a controlled substance under the Controlled Substances Act (CSA).

Images for W P97

Primaquine phosphate 26.3 mg (15 mg base) W P97
Primaquine phosphate 26.3 mg (15 mg base) W P97
Primaquine phosphate 26.3 mg (15 mg base) W P97

Primaquine Phosphate

W P97
26.3 mg (15 mg base)
Prescription only
Drug Class:
Antimalarial quinolines
Pregnancy Category:
N - Not classified
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Inactive Ingredients:
carnauba wax
magnesium stearate
microcrystalline cellulose
polyethylene glycol 400
polysorbate 80
ferric oxide red
magnesium silicate
titanium dioxide
hypromellose 2910 (15000 mPa.s)
corn starch
Note: Inactive ingredients may vary.

Other Labelers / Repackagers:

NDC CodeLabeler / Repackager
43063-0225 PDRX Pharmaceuticals Inc. (repackager)

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.